Living with Neuroendocrine Cancer, Patient Advocacy, Survivorship, TreatmentConstipation, Depression, Dry skin, Fatigue, Goitre, Graves’ disease, Hashimoto's disease, Heat intolerance, Hormones, Hyperthryroidism, Hypothyroidism, Lanreotide, Levothyroxine, NET syndromes, Neuroendocrine, Neuroendocrine cancer, Neuroendocrine tumour (NET), Octreotide, Palpitation, Pituitary gland, Quality of LIfe (QoL), Radioactive iodine, Somatostatin analogues, Sweating, Thyroid stimulating hormone (TSH), Thyroiditis, Thyroxine (T4), Triiodothyronine (T3)
From other posts, you'll be aware of the thyroid lesion (approx. 17 x 19mm) which I've been tracking since 2013. The surveillance included routine thyroid blood tests, mainly TSH, T3 and 4. I was out of range in TSH (elevated) but the T4 was at the lower end of the normal range. On 20 March 2018, following an Endocrine appointment, I was put on a trial dose of 50mcg of Levothyroxine to counter the downwards trend in results indicating hypothyroidism, possibly due to the lesion. Levothyroxine is a thyroid hormone (thyroxine) replacement. One month after taking these drugs, my thyroid…